BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38485910)

  • 1. A Quality-of-life Study in Patients with Anaphylaxis to Hymenoptera Venom in Iran.
    Bemaniyan MH; Heidari M; Tavakol M; Nabavi M; Ramezani Kashal F; Gholami M; Bemaniyan B
    Iran J Allergy Asthma Immunol; 2024 Feb; 23(1):59-68. PubMed ID: 38485910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the quality of life in subjects with a history of severe anaphylactic reaction to the Hymenoptera venom.
    Nowak N; Bazan-Socha S; Pulka G; Pełka K; Latra P
    Pneumonol Alergol Pol; 2015; 83(5):352-8. PubMed ID: 26378996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylaxis to Stinging Insect Venom.
    Adams KE; Tracy JM; Golden DBK
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):161-173. PubMed ID: 34823745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life in insect venom allergy: validation of the Turkish version of the "Vespid Allergy Quality of Life Questionnaire" (VQLQ-T).
    Sin BA; Öztuna D; Gelincik A; Gürlek F; Baysan A; Sin AZ; Aydın Ö; Mısırlıgil Z
    Springerplus; 2016; 5():583. PubMed ID: 27247880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vespid Allergy Quality of Life Questionnaire - cultural adaptation and translation to Portuguese.
    Silva D; Pereira AM; Santos N; Amaral L; Delgado L; Oude Elberink JN; Coimbra A
    Eur Ann Allergy Clin Immunol; 2017 May; 49(3):114-121. PubMed ID: 28497674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
    Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
    Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
    Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hymenoptera venom allergy: what's new in 2023].
    Belkoniene M; Ringwald M; Leimgruber A; Muller YD
    Rev Med Suisse; 2023 Apr; 19(821):663-667. PubMed ID: 37017347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life.
    Koschel DS; Schmies M; Weber CN; Höffken G; Balck F
    J Investig Allergol Clin Immunol; 2014; 24(4):226-30. PubMed ID: 25219104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in children and adolescents after systemic sting reaction.
    Brzyski P; Cichocka-Jarosz E; Tarczoń I; Jedynak-Wąsowicz U; Tomasik T; Lis G
    Ann Agric Environ Med; 2019 Mar; 26(1):103-108. PubMed ID: 30922038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom.
    Armisén M; Guspi R; Alfaya T; Cruz S; Fernández S; Domínguez-Noche C; Alonso A; Dalmau G; Marqués L; Vega A
    J Investig Allergol Clin Immunol; 2015; 25(3):176-82. PubMed ID: 26182683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.
    Wanandy T; Mulcahy E; Lau WY; Brown SGA; Wiese MD
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):123-144. PubMed ID: 34075569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insect allergy.
    Tracy JM
    Mt Sinai J Med; 2011; 78(5):773-83. PubMed ID: 21913205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and managing Hymenoptera venom allergy.
    Matron PK; Timms V; Fitzsimons R
    Nurs Stand; 2016 May; 30(39):44-51. PubMed ID: 27224630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hymenoptera Venom Allergy and Anaphylaxis.
    Bilò MB; Danieli MG; Moroncini G; Martini M
    Curr Pharm Des; 2023; 29(3):165-177. PubMed ID: 35980057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on venom allergy.
    Shaker MS; Hsu D; Gruenberg DA
    Curr Opin Pediatr; 2013 Oct; 25(5):629-34. PubMed ID: 23676715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy.
    Paolocci G; Folletti I; Torén K; Muzi G; Murgia N
    BMJ Open; 2014 Aug; 4(8):e005593. PubMed ID: 25099935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.